Item Type | Name |
Academic Article
|
Is occupational organic solvent exposure a risk factor for scleroderma?
|
Academic Article
|
Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.
|
Academic Article
|
IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis.
|
Academic Article
|
Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
|
Academic Article
|
Immunoglobulin GM and KM allotypes and vaccine immunity.
|
Academic Article
|
Hepatitis C virus core protein discriminates between the two IgG2 allotypes.
|
Academic Article
|
Immunoglobulin GM and KM allotypes and antibody responses to Epstein-Barr virus antigens.
|
Academic Article
|
Antigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria.
|
Academic Article
|
Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
|
Academic Article
|
Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes.
|
Academic Article
|
Humoral immunity to cytomegalovirus and chronic graft-versus-host disease.
|
Academic Article
|
Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes.
|
Academic Article
|
Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients.
|
Academic Article
|
Immunoglobulin allotypes and virus antibodies in Finnish type 1 diabetic patients.
|
Academic Article
|
Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype.
|
Academic Article
|
Heterozygosity at the Km locus associated with humoral immunity to Campylobacter jejuni.
|
Academic Article
|
Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes.
|
Academic Article
|
Anticentromere antibody and immunoglobulin allotypes in scleroderma.
|
Academic Article
|
Immunoglobulin allotypes and immune response to meningococcal polysaccharides A and C.
|
Academic Article
|
Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.
|
Academic Article
|
Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis.
|
Academic Article
|
Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients.
|
Academic Article
|
Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis.
|
Academic Article
|
Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.
|
Academic Article
|
A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer.
|
Academic Article
|
Host and bacterial factors associated with Haemophilus influenzae type b disease in Minnesota children vaccinated with type b polysaccharide vaccine.
|
Academic Article
|
Familial clustering of scleroderma spectrum disease.
|
Academic Article
|
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
|
Academic Article
|
Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.
|
Academic Article
|
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides.
|
Academic Article
|
Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
|
Academic Article
|
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
|
Academic Article
|
Immunoglobulin kappa chain allotypes (KM) in onchocerciasis.
|
Academic Article
|
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides.
|
Concept
|
Antibodies, Helminth
|
Concept
|
Antibodies, Fungal
|
Concept
|
Antibodies, Neutralizing
|
Concept
|
Antibodies, Antinuclear
|
Concept
|
Antibodies, Antineutrophil Cytoplasmic
|
Concept
|
Antibodies
|
Concept
|
Antibodies, Viral
|
Concept
|
Antibodies, Bacterial
|
Concept
|
Antibodies, Protozoan
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Hepatitis C Antibodies
|
Concept
|
HIV Antibodies
|
Academic Article
|
Genetic etiology of schizophrenia: possible role of immunoglobulin ? genes.
|
Academic Article
|
Higher levels of antibodies to the tumour-associated antigen cyclin B1 in cancer-free individuals than in patients with breast cancer.
|
Academic Article
|
Immunoglobulin genes influence the magnitude of humoral immunity to cytomegalovirus glycoprotein B.
|
Academic Article
|
Humoral Immunity to Cytomegalovirus Glycoprotein B in Patients With Breast Cancer and Matched Controls: Contribution of Immunoglobulin ?, ?, and Fc? Receptor Genes.
|
Academic Article
|
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
|
Academic Article
|
Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.
|
Academic Article
|
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.
|
Academic Article
|
Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer.
|
Academic Article
|
Genetic variants of IgG1 antibodies and Fc?RIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells.
|
Academic Article
|
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
|
Academic Article
|
Rituximab therapy and the highly polymorphic Fc region of IgG: comment on the article by Cartin-Ceba et?al.
|
Academic Article
|
Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio.
|
Academic Article
|
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease.
|
Academic Article
|
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.
|
Academic Article
|
Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer's disease.
|
Academic Article
|
Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Academic Article
|
IgG3 constant region GM (? marker) allotypes could influence the neutralizing potency of anti-SARS-CoV-2 monoclonal antibodies.
|
Academic Article
|
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
|
Academic Article
|
Immunoglobulin ? chain allotypes and humoral immunity to HSV1 in Parkinson's disease.
|